Aurion Biotech
Facts
- HQ
- United States
- Sectors
- Biotechnology
- Founded
- 2022
- Employees
- 116
- Stage
- Clinical-stage
- Total raised
- $81.4M SEC Form D filings Total of this company's SEC Form D filings
- Last round
- $26.1M · Apr 2022 SEC Form D
Jacob Colker reflects on Hubble Network raised $200M at a $1.6B valuation in LinkedIn roundup of Seattle wins
A LinkedIn article by Jacob Colker (published Sep 29, 2026) highlights recent Seattle achievements, including Hubble Network raising $200 million at a $1.6 billion valuation to connect ordinary Bluetooth devices. The piece frames these stories as reminders that the Seattle region is more influential than commonly perceived.
Gennev Founder Jill Angelo Steps Down After Acquisition; Aurion Biotech CEO Replaced Following Alcon Majority Stake; Temporal Adds New Leadership
Jill Angelo, founder and CEO of menopause startup Gennev, stepped down following its acquisition by Unified Women’s Healthcare, while Aurion Biotech replaced CEO Greg Kunst with Arnaud Lacoste after Alcon acquired a majority stake. Temporal also announced leadership additions with Jim Cyb as president and Sahir Azam as an independent board member.
GeekWire 200 Q1 2025: Highspot Leads as Helion Rises to No. 2 After $425M Funding; Truveta, Statsig, Protect AI Also Advance
The GeekWire 200 Q1 2025 update highlights rapidly growing Pacific Northwest tech startups, with Highspot retaining No. 1 and Helion rising to No. 2 after a $425 million funding round. Other notable movers include Truveta, Statsig, Protect AI, Carbon Robotics, and Stoke Space, reflecting dynamic shifts in the regional tech landscape.
People
-
David Rostov Executive, Chief Financial Officer, Executive Officer
